The timing of treatment may be a key factor in whether hormone replacement therapy (HRT) can slow heart vessel disease, report researchers from Wake Forest University Baptist Medical Center and Tufts-New England Medical Center in the winter issue of Menopausal Medicine.
In the wake of recent reports showing a correlation between hormone replacement therapy (HRT), and serious illnesses such as stroke, breast cancer and heart disease, many women are looking elsewhere for treatment options for their menopausal symptoms. According to Duke OB/ GYN Claude Hughes, M.D., soy can be effective in treating some of the symptoms of menopause, which are caused by declining levels of estrogen. The most common symptoms include hot flushes (flashes), night sweats, mood swings, depression, forgetfulness, insomnia, as well as thinning of vaginal tissues and stress incontinence.
Another menopausal myth is challenged: Women with existing coronary disease do not realize improvement in their cognitive function as a result of taking the most common form of hormone replacement therapy, a UCSF study has found. Investigators followed more than 1000 women from ten US test sites for four years. Half took a placebo; the other half took hormone replacement therapy (HRT). Although other, smaller studies have shown an improvement, in the UCSF study the women who received HRT performed no better on standard tests of cognitive function than those who received placebo.
Despite recent reports that hormone therapy does not offer protection for post-menopausal females against heart disease and heart attack, researchers from Duke University Medical Center have determined in mouse studies that non-hormone treated pre-menopausal females are, in fact, better protected from cardiac damage following ischemia compared to their male counterparts. The findings suggest that research should continue toward finding better ways to treat post-menopausal women to maintain such cardiac protection, the researchers said.